Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
UMKC’s pitch competition showcases ‘real people’ solving real problems with $88K up for grabs
Seven ventures remain in a popular regional business challenge that culminates this week with $88,000 in prizes on the line. Many of the competitors: no strangers to the pitch stage. Finalist presentations in the Regnier Venture Creation Challenge are planned for in-person Friday afternoon, followed by an awards ceremony at the UMKC Bloch Executive Hall.…
Take a peek down Ludo’s lanes before Made in KC’s new shuffleboard bar opens in Midtown
When the team at Made in KC moved the local-first retailer’s flagship shop to Martini Corner in spring 2021, they immediately had a vision for what the multi-concept building could entertain, said Keith Bradley. The vision: a retro shuffleboard bar. “The idea for a shuffleboard bar sparked from two places. One was the desire we…
Entrepreneurs pack Union Station as Chamber showcases diversity of KC’s small biz scene
Editor’s note: The Greater Kansas City Chamber of Commerce is a non-financial partner of Startland News, which serves as the media partner for the Small Business Superstars program. A diverse cross-section of Kansas City small business owners filled the Grand Hall at Union Station with energy and enthusiasm Thursday, Vicky Kulikov said, noting a significant…
KC’s own $160M ‘urban oasis’ park: Private funders greenlit to put a 5.5-acre lid over I-670
Private backers have put up critical funding needed to begin reimagining the South Loop Link — bringing the long-dreamed about project closer to reality than ever before. Civic leaders from across the region gathered Friday to announce a verbal commitment from funders and local property owners — including Lowes’ Hotel & Co. — who will finance the engineering…